Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-03-11

FDA Approved: YAZ — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Yaz (drospirenone and ethinyl estradiol) from Bayer HealthCare Pharmaceuticals, indicating a label-related or fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • YAZ (DROSPIRENONE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for YAZ (DROSPIRENONE AND ETHINYL ESTRADIOL)